Metraipolis › archive › dc_f05fd1afd7ec

Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial — Europe PMC PMID:42098284

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42098284
DOI
10.1038/s43856-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-08T14:41:15.733Z
SHA-256 of the archived text
b07a954f36b38873331c322ddd649b24e07e51e93d3497093290f4cb490ba51a
Stable URL of this page
https://metraipolis.com/documento/dc_f05fd1afd7ec

How to cite

Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial — Europe PMC PMID:42098284 — Europe PMC (en), https://europepmc.org/article/MED/42098284 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f05fd1afd7ec (Metraipolis archive dc_f05fd1afd7ec, sha256 b07a954f36b38873331c322ddd649b24e07e51e93d3497093290f4cb490ba51a)
BibTeX
@misc{dcf05fd1afd7ec,
  title = {Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial — Europe PMC PMID:42098284},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42098284},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f05fd1afd7ec; sha256 b07a954f36b38873331c322ddd649b24e07e51e93d3497093290f4cb490ba51a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42098284. Agents can read the archived copy with the MCP tool read_document.